| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 02/25/1992 | US5091510 Retro-inverso analogues of thymopentin, and their use in the preparation of pharmaceutical compositions |
| 02/25/1992 | US5091367 Analogs of gonadoliberin with improved solubility, methods for their preparation, agents containing them and their use |
| 02/25/1992 | CA2049743A1 Bradykinin antagonists |
| 02/25/1992 | CA1296486C Therapeutic peptides |
| 02/24/1992 | WO1992003158A1 Nucleotide and amino acid sequences of protein mtp40 of m. tuberculosis and synthetic peptides derived therefrom |
| 02/24/1992 | CA2089888A1 Nucleotide and amino acid sequences of protein mtp40 of m. tuberculosis and synthetic peptides derived therefrom |
| 02/20/1992 | WO1992002623A1 CLONING AND EXPRESSION OF A RHOPTRY ASSOCIATED PROTEIN OF $i(P.FALCIPARUM) |
| 02/20/1992 | WO1992002555A1 A fibronectin binding peptide |
| 02/20/1992 | WO1992002546A1 Synthetic peptides that antagonize neurokinin a, their salts and their manufacturing processes |
| 02/20/1992 | WO1992002544A1 Peptides of the chromostatin family |
| 02/20/1992 | WO1992002543A1 Novel immunosuppressant peptides |
| 02/20/1992 | WO1992002248A1 Tachykinin agonists for treatment of alzheimer's disease |
| 02/20/1992 | WO1992002246A1 Growth factor compositions, preparation and use |
| 02/20/1992 | WO1991019743A3 Combined treatment with gnrh antagonist and gnrh to control gonadotropin levels in mammals |
| 02/20/1992 | WO1991019736A3 Cancer-associated scm-recognition factor, preparation and method of use |
| 02/20/1992 | WO1991019734A3 Thrombin inhibitors based on the amino acid sequence of hirudin |
| 02/20/1992 | DE4122094A1 1,1,3,3,-Bis-polymethylene-2-(hetero)aryl-uronium salts - are condensn. agents with improved solubility properties, esp. for use in automated peptide syntheses |
| 02/19/1992 | EP0471453A2 Cyclic HIV principal neutralizing determinant peptides |
| 02/19/1992 | EP0471356A1 Antigenic peptide for detecting anti-hepatitis C virus antibodies and use thereof |
| 02/19/1992 | EP0471028A1 Highly cytopathogenic hiv-ndk retrovirus, dna fragments of this retrovirus, method for preparing a protein and/or an enzyme of this virus, and the applications of these |
| 02/19/1992 | EP0470974A1 Lytic peptides, use for growth, infection and cancer |
| 02/18/1992 | US5089603 Antigenic epitopes present on membrane-bound but not secreted iga |
| 02/15/1992 | CA2048895A1 Antigenic peptide for detecting anti-hepatitis c virus antibodies and use thereof |
| 02/14/1992 | WO1992003476A1 Bioactive egf peptides for promotion of tissue regeneration and cancer therapy |
| 02/14/1992 | CA2088972A1 Bioactive egf peptides for promotion of tissue regeneration and cancer therapy |
| 02/12/1992 | EP0470565A1 Peptides with antigenic determinant characteristic for alpha 1-microglobulin |
| 02/12/1992 | EP0470175A1 Enzymatic membrane method for the synthesis and separation of peptides |
| 02/07/1992 | CA2048305A1 Peptides with a characteristic antigenic determinant for alphal-microglobulin |
| 02/06/1992 | WO1992001718A2 Functionally active selectin-derived peptides and ligand for gmp-140 |
| 02/06/1992 | WO1992001710A1 Anticoagulant peptides |
| 02/06/1992 | WO1992001707A1 Purification directed cloning of peptides |
| 02/06/1992 | WO1992001462A1 Amphiphilic peptide compositions and analogues thereof |
| 02/05/1992 | EP0469281A1 Amino acid residue sequence of hepatitis B core antigen |
| 02/05/1992 | EP0193585B1 Cross-reactive and protective epitopes of circumsporozoite proteins |
| 02/04/1992 | WO1992002547A1 Method for treating immune system dysfunctions |
| 02/04/1992 | US5086165 Inhibitors of retroviral protease with a ketomethylene isosteric replaced amide bond |
| 02/04/1992 | US5086042 Capable of stimulating contraction of gall bladder; having six to nine amino acids with sulfonated tyrosine and C-terminal amides; treating obesity |
| 02/04/1992 | US5085055 For low energy desalting of sea water |
| 02/04/1992 | CA2088679A1 Method for treating immune system dysfunctions |
| 02/01/1992 | WO1992002545A1 Bombesin antagonists |
| 02/01/1992 | CA2088166A1 Peptides |
| 02/01/1992 | CA2048029A1 Amino acid residue sequence of hepatitis b core antigen |
| 01/29/1992 | EP0468527A2 Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines |
| 01/29/1992 | EP0468497A2 Peptide-antagonists of bombesin/GRP |
| 01/29/1992 | EP0468448A2 Analogs of hirudin having antiplatelet activity |
| 01/29/1992 | EP0468339A2 Alpha-keto-amide derivatives having protease inhibiting activity |
| 01/28/1992 | US5084555 Anticarcinogenic agents, gastrointestinal disorders and diabetic agents |
| 01/28/1992 | US5084444 Anticoagulants and enzyme inhibitors |
| 01/26/1992 | WO1992001787A1 Binding domains |
| 01/26/1992 | CA2087095A1 Binding domains |
| 01/25/1992 | WO1992001711A1 Polypeptide compounds having growth hormone releasing activity |
| 01/25/1992 | WO1992001709A1 Process for synthesizing peptides |
| 01/25/1992 | CA2086928A1 Polypeptide compounds having growth hormone releasing activity |
| 01/25/1992 | CA2086416A1 Process for synthesizing peptides |
| 01/23/1992 | WO1992000757A1 Diagnosis of metastatic cancer by the mts-1 gene |
| 01/23/1992 | CA2086829A1 Diagnosis of metastatic cancer by the mts-1 gene |
| 01/22/1992 | EP0467701A2 Cyclic HIV principal neutralizing determinant peptides |
| 01/22/1992 | EP0467699A2 Cyclic HIV principal neutralizing determinant peptides |
| 01/22/1992 | EP0467433A1 Use of a centrally acting ATCH analog in the manufacture of a medicament |
| 01/21/1992 | CA1294736C Renin inhibitors containing 5-amino-2,5-disubstituted- 4-hydroxypentanoic acid residues |
| 01/20/1992 | WO1992001691A1 New derivatives of streptogramines and preparation thereof |
| 01/20/1992 | WO1992001464A1 Inhibition of mac-1 receptor binding to fibrinogen using d30 homologs |
| 01/20/1992 | CA2087535A1 Streptogramines derivatives and their preparation |
| 01/20/1992 | CA2087169A1 Inhibition of mac-1 receptor binding to fibrinogen using d30 homologs |
| 01/20/1992 | CA2050635A1 Class ii protein of the outer membrane of neisseria meningitidis having immunologic carrier and enhancement properties, and vaccines containing same |
| 01/20/1992 | CA2047317A1 Amphiphilic peptide compositions and analogues thereof |
| 01/20/1992 | CA2047078A1 Cyclic hiv principal neutralizing determinant peptides |
| 01/20/1992 | CA2047042A1 Cyclic hiv principal neutralizing determinant peptides |
| 01/20/1992 | CA2047033A1 Cyclic hiv principal neutralizing determinant peptides |
| 01/19/1992 | CA2045714A1 Use of a centrally acting acth analog in the manufacture of a medicament |
| 01/15/1992 | EP0466565A1 Kit for the specific determination of Angiotensin II |
| 01/15/1992 | EP0466498A1 Physiologically active peptides having immunoregulatory activities |
| 01/14/1992 | US5081225 Gram-positive and gram-negative antibacterial compounds from the microorganism, janthinobacterium lividum |
| 01/14/1992 | US5081107 Bombesin or bombesin-like peptides antagonists; anticarcinogenic agents; antisecretory agents; glandular disorders |
| 01/13/1992 | WO1992001051A1 Immunogenic peptide sequence from echinococcus granulosus, dna sequence coding for said peptide sequence, and diagnostic and therapeutic uses thereof |
| 01/13/1992 | CA2087005A1 Immunogenic peptide sequence from echinococcus granulosus, dna sequence coding for said peptide sequence, and diagnostic and therapeutic uses thereof |
| 01/10/1992 | WO1992000996A1 Derivatives of pituitary posterior lobe hormones |
| 01/10/1992 | WO1992000995A1 Cyclic cell adhesion modulation compounds |
| 01/10/1992 | CA2087021A1 Cyclic cell adhesion modulation compounds |
| 01/10/1992 | CA2085603A1 Derivatives of pituitary posterior lobe hormones |
| 01/09/1992 | WO1992000091A1 Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
| 01/09/1992 | WO1991007483A3 Mammalian pancreatic cholesterol esterase |
| 01/08/1992 | EP0464147A1 Matrix metalloproteinase inhibitor peptides |
| 01/08/1992 | EP0462184A4 Method of treating viral infections using lfa-1 |
| 01/07/1992 | US5079366 Quarternary pyridinium salts |
| 01/07/1992 | US5079341 Antiinflammatory agents, antibody inhibitors |
| 01/07/1992 | US5079231 Immunostimulating peptides, a process for their preparation and pharmaceutical compositions containing them |
| 01/02/1992 | EP0464009A2 Oligopeptide derivatives of ipoxantine endowed with immunomodulating activity and pharmaceutical compositions containing same |
| 01/02/1992 | EP0463615A1 Process for the production of GnRH-decapeptides |
| 01/02/1992 | EP0463393A2 A mutant of bacillus subtiles and a method of producing surfactin with the use of the mutant |
| 01/02/1992 | EP0463081A1 Hormone response element compositions and assay |
| 01/02/1992 | EP0463070A1 A process for producing pentapeptides and intermediates for use in the synthesis. |
| 01/02/1992 | EP0463059A1 Allergenic proteins from ragweed and uses therefor |
| 01/02/1992 | EP0463053A1 Production and use of anthelmintic agents and protective immunogens |
| 01/02/1992 | EP0196319B1 Retroviral polypeptides associated with human cellular transformation |
| 01/01/1992 | CN1057465A Method for extraction of human chorionic gonadotropin from substance of induced abortion |
| 12/31/1991 | US5077285 Imidazole compounds and their use as transglutaminase inhibitors |
| 12/31/1991 | US5077195 Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor |
| 12/31/1991 | US5076973 Synthesis of dolastatin 3 |
| 12/31/1991 | CA2043618A1 Method for the production of gnrh-decapeptides |